The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions.
Mahima Agochiya , PhD, Business Development & Program Manager, SPARK Translational Research Program, Stanford University
Janice Bourque, Managing Director, Hercules Capital
Tony Butler, PhD, Managing Director, Senior Research Analyst & Head of Biotechnology Research, ROTH Capital Partners
Jason Camm, Managing Director and Chief Medical Officer, Thiel Capital LLC
Jung E. Choi, Chief Business & Strategy Officer, Global Blood Therapeutics
Shelley Chu, MD, PhD, Partner, Abingworth
Jennifer R. Cochran, PhD, Shriram Chair of the Department of Bioengineering, Stanford University
Grace Colón, PhD, President & Chief Executive Officer, InCarda Therapeutics